Member Focus

Member Focus invites ASCA members to express their views on key ASC issues. Share your perspective with your colleagues and get to know your peers in the ASC community.

Want to be the next featured member?

Answer one or both of the following questions:

Is your facility billing for non-opioid alternatives? Any words of advice to others?
Do you have a different time frame for H&Ps from the 30-day window? What criteria did you use to support making the change?

Questions? Write Sahely Mukerji.

Beth Russell, RN, CASC

Title: Vice President of Surgical Services
Facility Name: Knoxville Orthopaedic Clinic
City: Knoxville
State: Tennessee
Length of time your facility has been an ASCA member: Five or more years

Is your facility billing for non-opioid alternatives? Any words of advice to others?

We have recently started billing for non-opioid alternatives and are still early in the process, so we have not seen measurable results yet. Our initial focus has been on ensuring accurate documentation and appropriate coding to support reimbursement. We are also working closely with our clinical and billing teams to align workflows and avoid missed opportunities. As we gain more experience, we expect to better understand the financial and operational impact.

Do you have a different time frame for H&Ps from the 30-day window? What criteria did you use to support making the change?

We are still following the 30-day requirement for H&Ps and have not made any changes to that time frame. This ensures the H&Ps remain current and clinically relevant at the time of the procedure. It also maintains consistency in our documentation practices. At this time, we have not identified a need or supporting criteria to deviate from the 30-day standard.

Archive >